Pancreatic Cancer Research

ResearcherCentre Hospitalier Universitaire VaudoisActive in the last 2 years

Nicolas Demartines

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1530-3114; OpenAlex author ID A5063775633. Sources: OpenAlex.

Their work

Papers
11 (first author 4, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
17
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 11

  1. Percutaneous transhepatic recanalization of occluded prosthetic graft after pancreatoduodenectomy with venous reconstruction for pancreatic cancer. Co-author DOI 10.3389/fonc.2025.1575481↗
  2. Pancreatic Cancer Surgery: What Matters to Patients? Co-author DOI 10.3390/jcm12144611↗
  3. Reply to: Deep insight into lymph node metastasis in pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.ejso.2022.06.026↗
  4. Prediction of tumour grade and survival outcome using pre-treatment PET- and MRI-derived imaging features in patients with resectable pancreatic ductal adenoca… Co-author DOI 10.1007/s00330-020-07191-z↗
  5. Prognostic Impact of Time to Surgery in Patients With Resectable Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1097/mpa.0000000000001719↗
  6. Evidence for enhanced recovery in pancreatic cancer surgery. First author DOI 10.1007/s00423-020-01921-z↗
  7. A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivoluma… Co-author DOI 10.3389/fimmu.2019.01832↗
  8. Prognostic role of splenic vessel infiltration in distal pancreatic adenocarcinoma: Comment on: Systematic review and meta-analysis of prognostic role of splen… First author DOI 10.1016/j.ejso.2018.02.013↗
  9. Pancreatic adenocarcinoma with histologically proven portal vein infiltration: what is the outcome? Co-author DOI 10.1097/meg.0000000000001266↗
  10. Pancreatic cancer: are more chemotherapy and surgery needed? First author DOI 10.1016/s0140-6736(17)30126-5↗
  11. [Surgery for pancreatic adenocarcinoma: from established facts to changes in strategy?]. Last author PMID 26255494↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gaëtan‐Romain Joliat · 4 shared papers, 2018–2023 · strength 0.79
  2. Nermin Halkic · 4 shared papers, 2015–2025 · strength 0.57
  3. Didier Roulin · 2 shared papers, 2020–2025 · strength 0.48
  4. Markus Schäfer · 3 shared papers, 2018–2022 · strength 0.45
  5. Vincent Dunet · 2 shared papers, 2021–2025 · strength 0.39
  6. David J. Martin · 2 shared papers, 2018–2023 · strength 0.33
  7. Antonia Digklia · 2 shared papers, 2019–2025 · strength 0.32
  8. Nils Degrauwe · 1 shared paper, 2025 · strength 0.25
  9. Rafael Durán · 1 shared paper, 2025 · strength 0.25
  10. Stephen J. Wigmore · 1 shared paper, 2023 · strength 0.24
  11. Piero Alberti · 1 shared paper, 2023 · strength 0.24
  12. Michael H. Schneider · 1 shared paper, 2022 · strength 0.22
  13. David Petermann · 2 shared papers, 2015–2018 · strength 0.17
  14. Sabine Schmidt · 1 shared paper, 2021 · strength 0.15
  15. G. Deplanque · 1 shared paper, 2017 · strength 0.15
  16. Michal Bassani‐Sternberg · 1 shared paper, 2019 · strength 0.08
  17. Lana Elias Kandalaft · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.